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Four potential serine/threonine phosphorylation sites [(S/T)-P motif], designated P1–P4, on the pre-S protein of duck
hepatitis B virus (DHBV) have been mutated. Mutants include single (P2, P3, P4) and double amino acid substitutions (P11P2,
P31P4) and one with all four sites mutated (4P). Serine at position 118 (P3) was identified as the major site of phosphorylation
by Western blotting and radioimmunoprecipitation after in vitro cell labeling with [35S]methionine or [33P]orthophosphate.
Mutant virions generated by transfection of LMH cells were infectious both in vitro in duck hepatocyte primary cultures and
in vivo in Pekin ducks. Intracellular relaxed circular (RC) and covalently closed circular (ccc) DNA syntheses were not affected
by the P3 mutation or even the quadruple mutant. Extracellular virus production was slightly increased when the P3 site was
mutated. CsCl gradient centrifugation showed no clear difference between mutant and wild-type virus with respect to the
ratios of enveloped virus and nucleocapsid particles in hepatocyte culture supernatants. Trypsin or V8 protease digestion
with or without NP-40 indicated that phosphorylation of the pre-S domain is not involved in determining the transmembrane
topology of DHBV large protein. This phenotypic analysis indicates that DHBV pre-S phosphorylation has no apparent effect
on DHBV replication and formation of mature viral particles in duck hepatocyte primary culture and does not affect infectivity
in ducklings. © 1998 Academic Press
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INTRODUCTION
Hepadnaviruses consist of a family of small DNA viruses
that replicate in the liver through the reverse transcription of
a pregenomic RNA (Summers and Mason, 1982). Following
infection of hepatocytes, the relaxed circular (RC) DNA of
the virions is converted into a nuclear supercoiled or ccc
(covalently closed circular) DNA which serves as template
for the transcription of viral RNAs, including the pregenomic
RNA (Tuttleman et al., 1986a; Wu et al., 1990). Pregenomes
are then transported to the cytoplasm, encapsidated to-
gether with the viral DNA polymerase, and reverse tran-
scribed, leading to the synthesis of single-stranded cDNA
(the minus strand) followed by the formation of double-
stranded RC DNA to form the nucleocapsid (Mason et al.,
1982; Summers and Mason, 1982). These nucleocapsids
are then enveloped by interaction with the envelope pro-
teins and excreted. During infection, an amplification of the
initial ccc DNA molecules occurs through recycling of nu-
cleocapsids to the nucleus (Tuttleman et al., 1986a; Sum-
mers et al., 1990). This event leads to the formation of an
important stock of ccc DNA molecules (10 to 50 copies of
ccc DNA per nucleus) which is crucial for the maintenance
of viral replication.
The hepadnavirus envelope proteins play multiple
functional roles in viral replication, including virion mor-
phogenesis (Bruss et al., 1996) and excretion, receptor
binding (Neurath et al., 1986; Pontisso et al., 1989; Lam-
bert et al., 1991; Klingmu¨ller and Schaller, 1993; Pugh et
al., 1995), interaction with the nucleocapsid, and regula-
tion of ccc DNA amplification (Summers et al., 1990, 1991;
Lenhoff and Summers, 1994a,b). The duck hepatitis B
virus (DHBV) envelope contains two proteins which are
encoded by the same open reading frame and result
from translational initiation at two different initiation
codons: the major S (surface) protein (17 kDa), a trans-
membrane protein of 167 amino acids, and the larger of
these two proteins, L (35/36 kDa, 328 amino acids),
containing the S and pre-S domains. Like the L protein of
the human hepatits B virus (Bruss et al., 1994; Ostapchuk
et al., 1994; Prange and Streeck, 1995), the DHBV L
protein can exhibit a dual topology (Guo and Pugh, 1997).
In some molecules, the pre-S region is translocated
across the endoplasmic reticulum membrane, while in
others it remains in the cytosol. Thus, after budding of
mature virus particles, half of the molecules are dis-
played on the outside of the virus and are involved in the
specific binding to hepatocyte receptors. The cytosolic
pre-S may interact with the nucleocapsids and plays the
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role of a matrix protein. Recently, it has been suggested
that phosphorylation–dephosphorylation plays an impor-
tant role in the topological shift within the pre-S protein
(Grgacic and Anderson, 1994). The DHBV pre-S proteins
are mainly revealed by Western blot analysis as doublets
at 35 and 36 kDa which correspond, respectively, to the
nonphosphorylated and phosphorylated species. Since
the phosphorylated form P36 exhibited an apparently
internal disposition, the authors proposed a model in
which phosphorylation prevented the translocation of the
pre-S domain through the endoplasmic reticulum, result-
ing in a cytosolic distribution. In order to check this
hypothesis and to clarify the role of pre-S phosphoryla-
tion in the virus life cycle, we performed a phenotypic
analysis of different mutants of DHBV in which four
potential phosphorylation sites [(S/T)-P motif] on the
pre-S protein were mutated. This study allowed us to
clearly identify the major phosphorylation site of pre-S.
Mutant viruses unable to express a phosphorylated form
of pre-S were generated by transfection of LMH cells and
studied for their ability to infect and to replicate in duck
hepatocyte primary cultures.
RESULTS
Phosphorylation is not essential for virus production
in transfected cell lines
Grgacic and Anderson (1994) have shown that the
DHBV L envelope protein can exist in a phosphorylated
state and that phosphorylation occurs on serine (S) or
threonine (T) residues. The pre-S domain of the L protein
of DHBV contains four potential (S/T)-P phosphorylation
sites, which we call P1 to P4 starting from the N-terminus
of the protein. To assess the possible role of pre-S
phosphorylation in the virus life cycle, we mutated indi-
vidually or in combination the potential phosphorylation
sites (Fig. 1A). Note that in the double mutant P11P2 and
the quadruple mutant, it is the Pro residue of the P2
potential phosphorylation site which is mutated (see
Materials and Methods). In all cases, the mutations do
not affect the amino acid sequence of the overlapping
polymerase open reading frame.
Mutant and WT plasmid DNAs were then transfected into
the LMH cell line. All were found to be competent for the
synthesis of viral DNA and excretion of pre-S containing
viral particles (Figs. 1B and 1C). Western blot analysis of
pre-S proteins reveals that all mutants exibited the major
35-kDa band (P35), while the more slowly migrating spe-
cies of 36 kDa (P36), which corresponds to the phosphor-
ylated form of P35, was not found in mutants P3, P31P4,
and 4P. This result strongly suggests that P3 is the major
phosphorylation site of the pre-S protein.
Phosphorylation is not essential for virus infectivity
In order to test the infectivity of these viral particles,
culture supernatants of transfected LMH cells were con-
centrated by polyethylene glycol precipitation and used
to infect both primary cultures of duck hepatocytes and
1-day-old ducklings. Equivalent amounts of virus (esti-
mated by dot-blot hybridization) for each mutant, wild-
type preparation, or the positive control standard inocu-
lum (made from a pool of duck sera) were used to infect
hepatocyte cultures or ducklings. All mutants were found
to be infectious both in vivo (Fig. 1D) and in vitro (see
below), as demonstrated by the appearance of viral pro-
teins and DNAs in the sera of animals and in the super-
natants or lysates of hepatocyte cultures.
P3 is the major site of phosphorylation
To show clearly that the mobility shift observed when
the P3 site is mutated is due to the absence of phos-
phorylation and not to the substitution of serine by phe-
nylalanine, primary duck hepatocyte cultures infected
with mutant and wild-type viruses were labeled with
[33Pi] or [35S]methionine, and pre-S proteins were iso-
lated by immunoprecipitation. In the same experiment,
pre-S was also detected in unlabeled cells by Western
blotting. The results (Fig. 2A) showed that the 33Pi-la-
beled pre-S protein was undetectable in P3, P31P4, and
4P mutants, while it was present in wild-type and P11P2
and P4 mutants. Immunoprecipitation of [35S]methionine
neosynthesized pre-S proteins (data not shown) and
Western blot analysis (Fig. 2B) of cellular lysates con-
firmed this finding, with no changes for mutants P11P2
and P4 and disappearance of the phosphorylated spe-
cies P36 in mutants P3, P31P4, and 4P. Thus, the serine
residue at position 118 on the pre-S protein serves as the
major phosphate acceptor.
The absence of phosphorylation does not affect viral
replication or secretion in hepatocyte primary culture
To clarify the role of phosphorylation of pre-S in the
viral life cycle, we compared the replication of mutant
and wild-type viruses in primary hepatocyte cultures.
Viral particles obtained from the supernatant of trans-
fected LMH cells were used to infect duck hepatocytes.
Cells were harvested at day 8 postinfection and analyzed
for intracellular viral DNAs. No clear significant differ-
ence in the levels of RC and ccc DNA between wild-type
(WT) and the different mutants, including the quadruple
mutant, was observed (Fig. 3). Only a decrease in the
level of RC DNA and ccc DNA was observed for mu-
tant P2. It may be explained by the mutation of resi-
due T89, which belongs to a neutralization epitope,
83IPQPQWTP90 (Lambert et al., 1991). This mutation may
reduce the infectivity of the P2 mutant, without any cor-
relation with phosphorylation.
Similarly, DHBV DNA levels in the supernatants of
infected cells were almost identical for WT and mutants,
with a slight increase of viral excretion for the P3 and the
P31P4 mutants (Fig. 4A). Excreted viral DNA could cor-
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respond to either complete enveloped particles or to
immature nonenveloped capsids. Thus, viral particles in
hepatocyte culture supernatants were concentrated by
ultracentrifugation and then separated by isopycnic cen-
trifugation in a CsCl density gradient. Results (data not
shown) indicated that for wild-type approximatively half
of viral DNA sedimented at a density of 1.15 g/cm3 which
corresponds to the density of enveloped particles, and
the other half at a density of 1.3 g/cm2, which corre-
sponds to naked core particles. The same respective
proportions were found for all mutants, including P3.
Western blot analysis of these excreted viral particles
confirmed the presence of pre-S protein, while the phos-
phorylated species P36 is absent in mutants P3, P31P4,
and 4P (Fig. 4B).
The absence of phosphorylation does not affect the
transmembrane topology of the DHBV L protein
The lack of effect of these mutations on viral replica-
tion and secretion of viral particles suggests that the
phosphorylation–dephosphorylation has no significant
role in the topological shift within the L protein during
morphogenesis. In order to assess the topological dis-
FIG. 1. Effects of serine or threonine substitution in the the DHBV envelope protein. (A) Amino acid sequence of the N-terminal DHBV envelope pre-S
protein of the wild type (WT) and the various mutants. The four putative (S/T)-P phosphorylation sites are underlined. Mutants are named according
to the phosphorylation sites mutated. 4P is the quadruple mutant. (B and C) Analysis of DHBV DNA (B) and DHBV pre-S protein (C) in supernatants
of LMH cells transfected with the different phosphorylation mutants indicated in A. (D) Dot-blot hybridization of the sera of ducklings infected with
concentrated supernatants of LMH cells transfected with mutant or wild-type constructs. Control—duckling inoculated with concentrated supernatant
from mock-transfected LMH cells.
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position of the phosphorylated and nonphosphorylated
fractions of L, we assayed resistance of envelope pro-
teins to protease digestion as already described by Guo
and Pugh (1997). The sequence-specific endoprotease
V8 and trypsin were used to digest protein exposed on
the exterior of enveloped particles and polypeptides that
remained resistant to protease digestion were analyzed
by Western blotting, using antibodies specific to the S
and pre-S regions of L envelope protein. Virus prepara-
tions were digested in the presence or the absence of
NP-40 detergent, which solubilizes the virus lipid enve-
lope, exposing protease-sensitive sites on internal pre-S
to digestion.
The protease digestion of WT, P3, and 4P viral par-
ticles obtained by transfection in LMH cells revealed a
similar pattern (Fig. 5A), both qualitatively and quanti-
tatively. In particular, all preparations contain pre-S
and S fragments which are protected from protease
digestion in intact particles but which are degraded
when NP-40 is also included. This indicates that ex-
creted viral particles containing a nonphosphorylat-
able pre-S domain (mutants P3 and 4P) possess inter-
nally disposed pre-S protein in amounts comparable to
wild-type particles. These data do not, however, show
whether the nonphosphorylatable mutants contain the
same proportions of externally and internally localized
pre-S protein as wild-type particles. Therefore, we
spotted serial dilutions of intact wild-type and P3 mu-
tant virus onto membranes and probed with anti pre-S
and anti-S antibodies. The endpoint titer of pre-S de-
tection was the same (1:4096) for wild-type and P3
viruses. In the same way, the titration of S molecules in
wild-type and P3 preparations showed identical levels
of external S protein for both viruses (Fig. 5B).
These results indicated that phosphorylation of the
pre-S domain is not involved in determining the trans-
membrane topology of the DHBV L protein.
DISCUSSION
Grgacic and Anderson (1994) have shown that the
DHBV L envelope protein can exist in a phosphorylated
state and that phosphorylation occurs on S or T residues.
Yu and Summers (1994) have also shown that the core
protein of DHBV is phosphorylated on S/T residues, but
in a special context (S/T)-P. This is reminiscent of the
minimal consensus sequence for mitogen-activated pro-
tein (MAP) kinases (Clark-Lewis et al., 1991). To identify
the phosphorylation site(s) on the envelope protein of
DHBV, we have concentrated on the four (S/T)-P sites of
the pre-S region. Site-directed mutagenesis clearly
shows that it is the third motif, P3, which is the major site
of phosphorylation, as has also been shown by the
groups of Anderson and of Schaller (D. Anderson and H.
Schaller, personal communications). When this site is
mutated, we find no phosphorylated pre-S protein, either
by Western blot or by immunoprecipitation of 33Pi-labeled
cell extracts. Mutation of the three other potential sites
does not abolish phosphorylation. This does not neces-
sarily mean that the other sites cannot be phosphory-
lated. Phosphorylation at P3 may be necessary before
secondary phosphorylation at other sites can occur.
However, of the four (S/T)-P motifs, only P3 conforms to
FIG. 3. Analysis of intracellular DHBV DNA synthesized by primary
culture of hepatocytes infected with the indicated mutants. Cells were
harvested at day 8 postinfection and replicative intermediates, relaxed
circular (RC) and single stranded (ss) DNAs, and covalently closed
circular DNA (ccc) were isolated as described under Materials and
Methods. WT, wild type.
FIG. 2. Analysis of pre-S proteins of the various mutants by SDS–
PAGE. Primary culture hepatocytes were infected with DHBV particles
produced by transfection of LMH cells with the different mutants or WT
DNAs. (A) Hepatocyte primary cultures were labeled for 48 h with 33Pi
starting at day 3 postinfection with the various mutants. Cells were
lysed in RIPA buffer and labeled pre-S protein was isolated by immu-
noprecipitation with a rabbit polyclonal antibody and protein A/G aga-
rose. (B) Hepatocyte primary culture cells were harvested at day 8
postinfection and pre-S protein was detected in the crude lysate by
Western blotting. Each lane corresponds to 10 mg of cellular protein.
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the prefered consensus for MAP2 kinases, P-X-(S/T)-P
(Clark-Lewis et al., 1991; David et al., 1995). A similar site
exists in the pre-S regions of the mammalian hepadna-
viruses, but in many strains the X residue is also a
proline, which is thought to be detrimental to phosphor-
ylation (Clark-Lewis et al., 1991). The P3 site is also
absent in the other avian hepadnavirus, HHBV, but a
sequence motif TPPP in the pre-S1 domain of all HHBV
genomes may serve as an alternative site (Netter et al.,
1997). It remains to be seen whether the pre-S proteins of
the mammalian hepadnaviruses are also phosphory-
lated.
Although phosphorylation of DHBV pre-S protein is
clearly a reality, abolition of phosphorylation has remark-
ably little effect on the virus life cycle. Transfection of
mutant genomes into LMH cells results in viral replica-
tion and excretion of pre-S containing viral particles.
Unlike mutants of WHV X protein, which are replication
competent but produce noninfectious particles (Blum et
al., 1992; Zoulim et al., 1994), the DHBV pre-S mutant
particles are fully infectious, both in vitro in primary
hepatocyte culture and in vivo in ducklings. There is little
difference in the behavior of the mutants and the wild
type, even in the case of the quadruple mutant.
Grgacic and Anderson (1994) have proposed that
phosphorylation–dephosphorylation of the pre-S protein
may play a role in the dual membrane topology of this
protein. When phosphorylated, the pre-S region can be
maintained on the intracellular side of the endoplasmic
reticulum membrane. Upon dephosphorylation, the pre-S
FIG. 4. (A) Analysis of extracellular DHBV DNA in supernatants of hepatocyte primary cultures infected with the indicated mutants at days 4, 6, 8,
10 postinfection. WT, wild type. (B) Viral particles in culture supernatants of hepatocytes infected with the different mutants were concentrated by
ultracentrifugation and then analyzed for pre-S protein by Western blotting.
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region can then translocate to the extracellular side of
the lumen, opening the way for secretion of viral parti-
cles. In such a model, one could expect that a nonphos-
phorylatable mutant may show higher levels of secretion
of viral particles than the wild type, with a concommitant
reduction in the levels of intracellular nucleocapsids.
This in turn could lead to a reduction in the accumulation
of ccc DNA, since there are fewer nucleocapsids avail-
able for recycling to the nucleus. This could be extremely
important, since it is thought that maintenance of ccc
DNA during antiviral treatments is responsable for the
rebound in viral replication usually observed at the end
of treatment. At present, we have no means of affecting
ccc DNA levels. However, while the P3 mutant does
show a small but reproducible increase in the excretion
of viral particles in primary hepatocyte culture when
compared with wild type, levels of intracellular RC forms
are also slightly elevated, and we note no difference in
the levels of ccc DNA for any of the mutants.
We also investigated the membrane topology of the L
protein from wild-type and mutant viruses. By Western
blot analysis, wild-type and mutant P3 or 4P display
FIG. 5. Topology analysis of DHBV L protein in WT and P3 extracellular particles. (A) Trypsin and V8 protease sensitivity in the presence or the
absence of NP-40 of partially purified viral particles from culture supernatants of LMH cells transfected with WT or P3 DNAs. Membranes were probed
with antibodies specific for the S (MAb 7C.12 ) or pre-S (rabbit polyclonal) regions of the DHBV envelope. L, intact DHBV L protein; p20S-T/S, DHBV
S protein, which is resistant to protease digestion; p20S-V, p20pS-T, p16pS-V, and p12S-T - proteolytic fragments. The terminology used is from Guo
and Pugh. (B) Relative quantification of WT and P3 external DHBV L protein on extracellular particles. Intact viral particles (the same preparations as
above) were serially diluted and spotted on immobilon P membranes. The membranes were probed with antibodies specific for the S (MAb 7C.12 )
or pre-S (rabbit polyclonal) regions of the DHBV envelope.
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similar profiles after trypsin or V8 digestion with or with-
out the detergent NP-40. These results, similar to those
reported by Guo and Pugh (1997), showed that a mixed
membrane topology of the L protein exists in both wild-
type and mutant P3 particles. This indicates that phos-
phorylation–dephosphorylation is not essential for trans-
location of the L protein and is in agreement with the lack
of the effects of abolition of phosphorylation of viral
replication. It is possible that lack of phosphorylation of
the pre-S protein may affect long-term infection of ducks,
perhaps by affecting the fitness of the virus. It would be
interesting to establish chronic infections of female
ducklings with the phosphorylation mutants and study
viremia in these animals and in their subsequent prog-
eny. However, it will be difficult to discriminate between
an effect on viral fitness due to the defect in phosphor-
ylation and that potentially due to the mutations we have
introduced into the pre-S region. Nevertheless, it is clear
from our results that phosphorylation–dephosphorylation
of the DHBV pre-S domain is not essential for viral
infectivity per se. A similar conclusion has recently been
drawn concerning phosphorylation of the M protein of
Sendai virus (Sakaguchi et al., 1997).
MATERIALS AND METHODS
Construction of plasmids
The wild-type plasmid is pCMV-DHBV (Condreay et al.,
1990), which contains the DHBV strain sequenced by
Mandart et al. (1984). The pre-S region of the DHBV large
envelope protein contains four (S/T)-P sites which are
potentially phosphorylatable, designated P1 to P4 from
the N-terminus. P2 (residues 89TP90) forms part of a
neutralization epitope which has been studied exten-
sively in our laboratory (Lambert et al., 1991; Chassot et
al., 1993, 1994), and we had at our disposition a variant in
which P90 had mutated to a His residue. This background
was used to create, by site-directed mutagenesis, a
double mutant P11P2 in which the Thr of P1 (79TP80) is
changed to Ile. In the course of site-directed mutagene-
sis of the neutralization epitope, a simple P2 mutant in
which Thr is changed to Ile was also obtained. The Ser
and Thr of P3 (118SP119) and P4 (155TP156) were changed
individually to Phe and Ile, respectively. An individual P1
mutant was not obtained. Using appropriate restriction
enzyme sites, mutants P3 and P4 were combined to give
P31P4, and P11P2 and P31P4 were combined to give
P11P21P31P4.
Transfection of LMH cells
LMH cells, a well-differentiated chicken hepatoma cell
line (Kawaguchi et al., 1987), were grown in Dulbecco’s
modified Eagle’s medium/F12 (1:1, Gibco-BRL) with 10%
fetal bovine serum at 37°C. For transfections, cells were
plated out at a density of about 3 3 106 cells/75-cm2
flask. The next day, plasmids (25 mg/flask) were trans-
fected using the calcium phosphate coprecipitation
method (Gornam, 1995). After overnight incubation, the
precipitate was removed and medium was renewed
daily. Culture fluids were harvested daily between days 5
and 7 posttransfection, clarified by centrifugation at 1000
g for 10 min, and stored at 4°C. They were pooled and
virus particles were precipitated by the addition of 1/3 vol
of a solution of polyethylene glycol (MW 8000), 26%;
NaCl, 1.4 M; EDTA, 25 mM; and incubation overnight at
4°C. The precipitates were collected by centrifugation at
1000 g for 60 min and dissolved in 1.5 ml of hepatocyte
culture medium.
Infection of primary hepatocyte cultures
Hepatocytes were isolated from 3-week-old Pekin
ducklings by in situ double-step collagenase perfusion of
their livers (Fourel et al., 1989). A unique lot of Collage-
nase (Type V, Sigma, 230 units/mg), selected on the
basis of the viability of the cells and their susceptibility to
DHBV infection, was used in this study. Cell aggregates
were removed through a nylon mesh (60-mm pore size)
and damaged cells by centrifugation through isotonic
Percoll solution. Cell viability was assessed by the trypan
blue exclusion test and was usually greater than 80%.
Hepatocytes were seeded on six-well plates at a low
density of approximately 2.5 3 105 cells per well in L15
medium supplemented with 5 3 10-5 M hydrocortisone
hemisuccinate, 5 mg of bovine insulin/ml, and 10% fetal
calf serum. Twelve hours after seeding, the medium was
discarded and replaced with the same medium without
fetal calf serum. Cultures were incubated at 37°C in a
humid atmosphere containing 5% CO2, and media were
changed on days 1 and 2 and then every 2 days for the
duration of experiments. For infections, 100 ml of virus
samples concentrated as above, containing approxi-
mately 5 3 1010 DNA genome equivalents/ml, were used
to infect duck hepatocyte cultures 1 day after plating by
addition of the virus to the culture medium and an incu-
bation for 20 h at 37°C. An inoculum consisting of a pool
of DHBV-positive sera obtained from 2-week-old experi-
mentally infected ducks was used as a positive control of
infection (Lambert et al., 1991).
Infectivity of pre-S mutants in vivo. Three-day old
DHBV-free Pekin ducklings were intravenously inocu-
lated with concentrated LMH supernatants (approxi-
mately 5 3 108 DNA genome equivalents per animal).
Viremia was followed daily during the first week postin-
oculation, and then every 3 days, by dot-blot hybridiza-
tion (see below).
Assay of infected hepatocytes for viral DNA. Primary
hepatocytes were harvested at day 8 postplating. Viral
DNA replicative intermediates and ccc DNA were as-
sayed as previously described (Summers et al., 1990).
Briefly, cell layers were washed once with HEPES-buff-
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ered saline and lysed with buffer containing 0.5% SDS.
Protein-bound replicative forms were precipitated as a
protein–detergent complex by addition of KCl to a final
concentration of 0.5 M. After centrifugation, ccc DNA,
along with genomic DNA, was recovered from the solu-
ble fraction by phenol extraction and ethanol precipita-
tion. Replicative forms (RC and ss DNA) were dissolved
by digestion of the pellet with proteinase K (0.83 mg/ml)
for 4 h at 55°C and purified by phenol extraction and
ethanol precipitation. For the samples containing DHBV
ccc DNA and cellular DNA, the same quantity of total
DNA was analyzed by 1.1% agarose gel electrophoresis
and transfer to an amphoteric nylon membrane (Biodyne
A-Pall filtron). For the KCl pellets (RC DNA), equal ali-
quots of the samples were analyzed. Hybridizations with
a 32P-labeled full-length genomic DHBV probe were per-
formed as described previously (Lambert et al., 1991).
Analysis of intracellular viral proteins in infected
hepatocytes: Western blot analysis
At day 8 postplating, aliquots of the cell lysates pre-
pared for the analysis of viral DNA were used for the
analysis of viral proteins. The protein concentration of
each sample was determined using the BCA Protein
Assay Reagent (Pierce). After addition of an equal vol-
ume of 23 Laemmli sample buffer, lysates were boiled
and 10-mg aliquots of protein were fractionated by SDS–
PAGE (12% acrylamide, 0.4% bis) and then transferred
onto an Immobilon P membrane (Millipore). Nonspecific
binding sites were blocked with 5% milk, 0.1% Tween 20
in phosphate-buffered saline (PBS) for 30 min. Mem-
branes were incubated for 1 h with a 1:1000 dilution of a
rabbit polyclonal antiserum directed against the DHBV
pre-S region (Lambert et al., 1991) and then with goat
anti-rabbit IgG antibodies conjugated to horseradish per-
oxidase (Dako) for 30 min at room temperature. The
membranes were washed (0.1% Tween 20 in PBS) and
revealed by chemiluminescence according to the man-
ufacturer’s instructions (ECL kit; Amersham).
Characterization of secreted particles in infected
hepatocytes or ducklings
(i) Quantification of secreted viral DNA: Dot-blot anal-
ysis. Aliquots of duck serum or of cell supernatants
removed at days 4, 6, 8, and 10 postplating were pipetted
onto a nitrocellulose membrane and denatured with
NaOH, 0.2 M; NaCl, 1 M; then neutralized with Tris–HCl,
0.5 M, pH 7.4; NaCl, 1 M; followed by a wash with 23
SSC; and fixed by baking for 2 h at 80°C. Hybridations
were done with a 32P-labeled genomic DHBV probe.
(ii) Assay for envelope proteins. Aliquots of cell super-
natants collected at day 8 were clarified and then ultra-
centrifuged for 2 h at 35,000 rpm (SW 41 rotor) at 4°C.
The pellets were resuspended and analyzed by the
Western blot procedure previously described.
(iii) CsCl gradient sedimentation analysis. Superna-
tants of infected hepatocytes were centrifuged in a linear
1.14 to 1.36 CsCl gradient (SW41 rotor at 35000 rpm for
20 h at 4°C). Fractions were monitored for DHBV DNA by
dot-blot analysis and for DHBV pre-S by Western blot
analysis as previously described.
(iv) Protease digestion. Trypsin and V8 protease (en-
doproteinase Glu-C) were purchased from Boehringer
Mannheim. DHBV particles were partially purified from
transfected LMH cells supernatants by PEG precipitation
followed by ultracentrifugation through a 10–20% (wt/vol)
sucrose gradient in an SW50 rotor at 45,000 rpm for 5 h
at 4°C. Virus pellets were resuspended in 20 mM Tris–
HCl(pH 8)-0.15 M NaCl, and digested with trypsin (20
mg/ml) or protease V8 (0.1 mg/ml) with or without addition
of NP-40 (0.5% vol/vol) as described (Guo and Pugh,
1997). After incubation for 2 h at 37°C, the samples were
heated for 5 mn at 95°C in 23 Laemmli sample buffer
and separated by SDS–PAGE (15% acrylamide). After
transfer onto an Immobilon P membrane (Millipore), S
and preS proteins were revealed as described above
using mouse monoclonal antibody anti-S 7C.12 (a kind
gift from John Pugh (Pugh et al., 1995) and anti-DHBV/
pre-S rabbit polyclonal antibodies.
(v) Quantification of Pre-S and S protein in WT and P3
viral particles. The same samples prepared for the
protease digestion analysis were diluted (1:2 to
1:16,384) in TNE and spotted onto an immobilon P
membrane (Millipore). S and preS proteins were re-
vealed as described above, except that detergent
(Tween 20) was omitted from the wash buffer, using
mouse monoclonal antibody anti-7C.12 and anti-DHBV/
preS rabbit polyclonal antibodies.
Metabolic labeling of infected primary hepatocytes
with [33Pi]- and [
35S]methionine and
radioimmunoprecipitation of the DHBV
pre-S protein
Four days postplating, cells were rinsed twice with
phosphate-free or methionine/cysteine-free minimal es-
sential Eagle’s medium, starved for phosphate or methi-
onine/cysteine in the same medium for 6 h, and subse-
quently labeled for 2 days with 100 mCi of 33Pi (Amer-
sham) or 200 mCi of Tran35S-label (ICN) in the starvation
medium. After labeling, the cells were rinsed twice with
ice-cold PBS and lysed with radioimmunoprecipitation
assay buffer (1% NP-40; 0.5% sodium deoxycholate; 0.1%
sodium deoxycholate sulfate in PBS). The lysates were
centrifuged at 13,000 rpm for 5 min. The supernatants
(cytosol) were incubated with anti-DHBV/pre-S rabbit
polyclonal antibodies at 4°C for 4 h and then with 20 ml
agarose conjugate (protein A/G PLUS, Santa Cruz Bio-
technology) at 4°C overnight. The immune complex was
washed seven times with the radioimmunoprecipitation
assay buffer and resuspended in 23 Laemmli sample
97PHOSPHORYLATION OF DHBV PRE-S
buffer. The samples were boiled for 5 min and electro-
phoresed on a SDS–PAGE polyacrylamide gel (12% acryl-
amide, 0.4% bis). Gels were dried and autoradiographed.
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